Dr. Melotek is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8980 S US Highway 1
Ste 105
Port St. Lucie, FL 34952Phone+1 772-281-3060Fax+1 772-281-3055
Education & Training
University of Chicago/University of Illinois College of Medicine at ChicagoResidency, Radiation Oncology, 2013 - 2017- University of ChicagoInternship, Internal Medicine, 2012 - 2013
University of Florida College of MedicineClass of 2012
Certifications & Licensure
FL State Medical License 2017 - 2026
IL State Medical License 2015 - 2020- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society, 2011
Publications & Presentations
PubMed
- 43 citationsA Phase I Trial of Concurrent Or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients with Stage IV Non-Small Cell Lung Cancer (COSINR Study)Christine M. Bestvina, K.B. Pointer, Theodore Karrison, Hania A. Al-Hallaq, Philip C. Hoffman
Journal of Thoracic Oncology. 2021-09-06 - 408 citationsSafety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors.Jason J. Luke, Jeffrey Lemons, Theodore Karrison, Sean P. Pitroda, J.M. Melotek
Journal of Clinical Oncology. 2018-02-13 - 31 citationsFinal Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for L...Tanguy Y. Seiwert, J.M. Melotek, Elizabeth A. Blair, Kerstin M. Stenson, Joseph K. Salama
International Journal of Radiation Oncology, Biology, Physics. 2016-09-01
Journal Articles
- OPTIMA: A Phase II Dose and Volume De-Escalation Trial for Human Papillomavirus-Positive Oropharyngeal CancerL Portugal, E A Blair, J M Melotek, M W Lingen, N Agrawal, A Dekker, Z Gooi, D T Ginat, C C Foster, E E Vokes, D J Haraf, Annals of Oncology
Press Mentions
Role of Cetuximab Expands in Head and Neck CancerJune 2nd, 2016
Professional Memberships
- Fellow
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
